chr17-58525752-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001368771.2(SEPTIN4):c.2035G>A(p.Val679Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,614,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001368771.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEPTIN4 | NM_001368771.2 | c.2035G>A | p.Val679Ile | missense_variant | 6/14 | ENST00000672673.2 | |
SEPTIN4-AS1 | NR_110810.1 | n.193C>T | non_coding_transcript_exon_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEPTIN4 | ENST00000672673.2 | c.2035G>A | p.Val679Ile | missense_variant | 6/14 | NM_001368771.2 | P1 | ||
SEPTIN4-AS1 | ENST00000580589.5 | n.193C>T | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251468Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135914
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461864Hom.: 1 Cov.: 30 AF XY: 0.0000633 AC XY: 46AN XY: 727236
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.481G>A (p.V161I) alteration is located in exon 4 (coding exon 4) of the SEPT4 gene. This alteration results from a G to A substitution at nucleotide position 481, causing the valine (V) at amino acid position 161 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at